<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00476125</url>
  </required_header>
  <id_info>
    <org_study_id>2007P000017</org_study_id>
    <nct_id>NCT00476125</nct_id>
  </id_info>
  <brief_title>Effects of Dietary Manipulation on Metabolism in Healthy Adults</brief_title>
  <official_title>Effects of Dietary Manipulation on Metabolism in Healthy Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beth Israel Deaconess Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beth Israel Deaconess Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will examine the potential changes in the blood levels of a recently discovered&#xD;
      metabolic regulator in response to changes in diet in healthy adults. Our hypothesis is that&#xD;
      in healthy adults key regulatory factors involved in lipid oxidation will respond to changes&#xD;
      in diet, particularly fasting and diet-induced ketosis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      There is scant data regarding the metabolic events that occur in humans during ketosis which&#xD;
      may be brought about by fasting or ingestion of diets low in carbohydrate.&#xD;
&#xD;
      We aim to employ both fasting and dietary manipulation in order to bring about a ketotic&#xD;
      state in healthy human adults. During the study blood levels of key metabolic regulators will&#xD;
      be monitored 1) during a 16 hour fast followed by re-feeding and 2) during dietary induction&#xD;
      of ketosis followed by re-feeding with a standard meal.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">March 2008</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">May 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in circulating plasma levels of key metabolic regulators</measure>
    <time_frame>1 week</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>A secondary outcome is change in energy expenditure with diet-induced ketosis.</measure>
    <time_frame>1 week</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Metabolic Regulation</condition>
  <condition>Fasting</condition>
  <condition>Ketogenic Diet</condition>
  <arm_group>
    <arm_group_label>3 day ketogenic diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>12 day ketogenic diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>16 hour fast</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Dietary manipulation ketogenic diet</intervention_name>
    <description>Subjects will consume a ketogenic diet for 3 days.</description>
    <arm_group_label>3 day ketogenic diet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Dietary Manipulation - 12 day ketogenic diet</intervention_name>
    <description>Subjects will consume a ketogenic diet for 12 days.</description>
    <arm_group_label>12 day ketogenic diet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>16 Hour Fast</intervention_name>
    <description>Subjects will fast for 16 hours.</description>
    <arm_group_label>16 hour fast</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          1. Men and women ages 18-60&#xD;
&#xD;
          2. BMI 21-28 kg/m2&#xD;
&#xD;
          3. Stable weight (variation &lt; 3 kg within 6 months of screening visit)&#xD;
&#xD;
          4. Ability to give informed consent&#xD;
&#xD;
          5. Ability to follow verbal and written instructions in English&#xD;
&#xD;
          6. Use of medically approved form of contraception (monophasic oral contraception, intra&#xD;
             uterine device, surgical sterilization or 2 combined barrier methods)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Type 1 or type 2 diabetes mellitus diagnosed according to American Diabetes&#xD;
             Association criteria&#xD;
&#xD;
          2. Coronary heart disease (history of myocardial infarction, unstable angina pectoris, or&#xD;
             congestive heart failure)&#xD;
&#xD;
          3. Uncontrolled hypertension (BP &gt; 150/90 mmHg on or off antihypertensive medication)&#xD;
&#xD;
          4. Dyslipidemia&#xD;
&#xD;
          5. Tobacco, marijuana or intravenous drug use&#xD;
&#xD;
          6. Shift workers (night shift or alternating day/night shifts)&#xD;
&#xD;
          7. Recent weight loss (&gt; 3 kg within 6 months of the screening visit)&#xD;
&#xD;
          8. Gastroparesis&#xD;
&#xD;
          9. Inflammatory bowel disease&#xD;
&#xD;
         10. Malignancy treated with chemotherapy within the past 3 years&#xD;
&#xD;
         11. History of pancreatitis&#xD;
&#xD;
         12. Depression or psychosis&#xD;
&#xD;
         13. Renal insufficiency (creatinine clearance &lt; 50 ml/min)&#xD;
&#xD;
         14. Transaminases &gt; 2x above the normal range&#xD;
&#xD;
         15. Known liver disease&#xD;
&#xD;
         16. Pregnancy within 6 months of the screening visit&#xD;
&#xD;
         17. Lactation&#xD;
&#xD;
         18. Failure to use medically approved contraceptive methods&#xD;
&#xD;
         19. History of an eating disorder (anorexia, bulimia or laxative abuse)&#xD;
&#xD;
         20. History of surgery for the treatment of obesity (gastric banding, gastric bypass,&#xD;
             gastric stapling)&#xD;
&#xD;
         21. New diagnosis of hypo or hyperthyroidism within 1 year of screening visit&#xD;
&#xD;
         22. History of alcohol abuse within the past 5 years&#xD;
&#xD;
         23. Seizure disorder&#xD;
&#xD;
         24. Gout&#xD;
&#xD;
         25. Kidney stones&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eleftheria Maratos Flier, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beth Israel Deaconess Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>May 17, 2007</study_first_submitted>
  <study_first_submitted_qc>May 18, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 21, 2007</study_first_posted>
  <last_update_submitted>July 8, 2020</last_update_submitted>
  <last_update_submitted_qc>July 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beth Israel Deaconess Medical Center</investigator_affiliation>
    <investigator_full_name>Jody Dushay</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

